Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007315
Filing Date
2016-08-04
Accepted
2016-08-04 08:51:24
Documents
53
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q trvn-20160630x10q.htm 10-Q 1378164
2 EX-31.1 trvn-20160630ex3111e09d4.htm EX-31.1 15617
3 EX-31.2 trvn-20160630ex312171a06.htm EX-31.2 14818
4 EX-32.1 trvn-20160630ex321432812.htm EX-32.1 10088
5 EX-32.2 trvn-20160630ex32225f80b.htm EX-32.2 12004
  Complete submission text file 0001558370-16-007315.txt   5397562

Data Files

Seq Description Document Type Size
6 EX-101.INS trvn-20160630.xml EX-101.INS 1154757
7 EX-101.SCH trvn-20160630.xsd EX-101.SCH 30225
8 EX-101.CAL trvn-20160630_cal.xml EX-101.CAL 36094
9 EX-101.DEF trvn-20160630_def.xml EX-101.DEF 149637
10 EX-101.LAB trvn-20160630_lab.xml EX-101.LAB 359596
11 EX-101.PRE trvn-20160630_pre.xml EX-101.PRE 275041
Mailing Address 1018 WEST 8TH AVENUE, SUITE A KING OF PRUSSIA PA 19406
Business Address 1018 WEST 8TH AVENUE, SUITE A KING OF PRUSSIA PA 19406 610-354-8840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36193 | Film No.: 161805965
SIC: 2834 Pharmaceutical Preparations